JC
GNMX

JBF Capital’s Aevi Genomic Medicine Inc GNMX Stock Holding History

JBF Capital’s Portfolio GNMX Stock Details GNMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-187,945
Closed -$27K – 94
2019
Q4 		$27K Buy
+187,945
New +$25.6K ﹤0.01% 72

JBF Capital's GNMX Position: Q1 2020 in Review

JBF Capital sold out of Aevi Genomic Medicine Inc (GNMX) in Q1 2020, closing a stake of 187,945 shares — an estimated $27K sold.

JBF Capital first reported a position in GNMX in Q4 2019 and held it in 1 quarter. The position peaked at $27K in Q4 2019. 2 funds tracked by Wall St. Rank hold GNMX as of Q1 2020.

  • JBF Capital reported no remaining Aevi Genomic Medicine Inc position as of Q1 2020 after selling out during the quarter.
  • JBF Capital sold 187,945 Aevi Genomic Medicine Inc shares in Q1 2020, an estimated $27K.
  • JBF Capital first reported a position in Aevi Genomic Medicine Inc in Q4 2019 and held it in 1 quarter.
  • JBF Capital's Aevi Genomic Medicine Inc position peaked at $27K in Q4 2019.
  • 2 funds tracked by Wall St. Rank held Aevi Genomic Medicine Inc as of Q1 2020.

Based on JBF Capital's 13F filing for Q1 2020, filed 15 May 2020.